A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis-Reference-Cited by-同舟云学术

A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis

Published:2016-03 Issue: Volume:42 Page:82-87
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Minakata Daisuke^ORCID,Fujiwara Shin-ichiro,Ito Shoko,Mashima Kiyomi,Umino Kento,Nakano Hirofumi,Kawasaki Yasufumi,Sugimoto Miyuki,Yamasaki Ryoko,Yamamoto Chihiro,Ashizawa Masahiro,Hatano Kaoru,Okazuka Kiyoshi,Sato Kazuya,Oh Iekuni,Ohmine Ken,Suzuki Takahiro,Muroi Kazuo,Kanda Yoshinobu^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Surveillance, Epidemiology, and End Results program: SEER Cancer Statistics Review 1975–2009. http://seer.cancer.gov/archive/csr/1975_2009_pops09/.

2. Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia;Jin;Leuk. Lymphoma,2015

3. Management of older or unfit patients with acute myeloid leukemia;Walter;Leukemia,2015

4. I treat the older patients with acute myeloid leukemia;Ossenkoppele;Blood,2015

5. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group;Lowenberg;J. Clin. Oncol.,1989

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation;Leukemia Research;2022-10

2. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy;International Journal of Hematology;2022-04-08

3. Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study;International Journal of General Medicine;2021-09

4. Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study;Blood Advances;2021-03-31

5. Femoral marrow MRI is a non-invasive, non-irradiated and useful tool for detecting bone marrow involvement in non-Hodgkin lymphoma;Journal of Clinical and Experimental Hematopathology;2021